InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.00%
)
US TECH 100
18,932.80
(
-0.42%
)
Dow Jones
41,393.78
(
0.00%
)
Brent Oil
71.93
(
0.76%
)
Bitcoin
58,613.60
(
-0.95%
)
Post# of 253125
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120436
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rwdm post# 126727

Tuesday, 09/20/2011 8:18:22 AM

Tuesday, September 20, 2011 8:18:22 AM

Post# of 253125
Yet another clueless blog from Seeking Alpha:

http://seekingalpha.com/article/294659-merck-s-curious-ms-acquisition-was-a-gamble-worth-taking

Merck's Curious MS Acquisition Was A Gamble Worth Taking

The odds may be extremely long, but when the wager is just $1.5m for a phase II-ready product in a major therapeutic area, it may just be worth a flutter. That could be the thinking behind Merck KGaA’s (MRK) decision to acquire PI-2301 from the bankrupt debris of Peptimmune…

Merck KGaA is not MRK. LMAO

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up